1. Barbaccia, M.L., and Costa, E. (1984). Autacoids for drug receptors: A new approach in drug development. Presynaptic modulation and presynaptic receptors in mental disease. Ann. N. Y. Acad. Sci., 430, 103–14.
2. Baron, M., Barkai, A., Gruen, R., Peselow, E., Fieve, R.R., and Quitkin, F. (1986). Platelet 3H-imipramine binding in affective disorders: trait versus state characteristics. Am. J. Psychiatry, 143, 711–17.
3. Briley, M., Langer, S.Z., Raisman, R., Sechter, D., and Zarifian, E. (1980). Tritiated imi-pramine binding sites are decreased in platelets of untreated depressed patients. Science, 209, 303–5.
4. Briley, M. (1985). Imipramine binding: its relationship with serotonin uptake and depression. In Green, A.R. (ed.), Neuropharmacology of Serotonin. Oxford University Press, Oxford, 21–49.
5. Briley, M. (1986). Midalcipran hydrochloride. Drugs of the Future, 11, 21–23.